Clinical Trial Update: Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing adding cyclophosphamide to standard immunosuppressive therapy with herombopag as front-line treatment for severe aplastic anemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Herombopag (herombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Severe Aplastic Anemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING